Evoke Pharma announced that Matthew D’Onofrio will be succeeding David Gonyer as CEO as of March 31, upon Gonyer’s departure for personal reasons. D’Onofrio currently serves as president and COO. In tandem with his new executive responsibilities, D’Onofrio will assume Gonyer’s board seat as of March 31.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVOK:
- Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer
- Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
- Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
- EVOK Earnings this Week: How Will it Perform?
- Evoke Pharma Faces Nasdaq Delisting Over Stock Price
